Related Experiment Video
Updated: Jun 18, 2026
12:24
Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
9.4K
Systematic Review: The Impact of COVID-19 Vaccination on Myocarditis Risk and Recovery
Yibo Liu1, Christopher Khatchadourian2,3, Luke Sanders1
1Department of Biomedical Sciences, Kansas College of Osteopathic Medicine, Wichita, KS 67202, USA.
Clinics and Practice
|April 27, 2026
Summary
Myocarditis after mRNA COVID-19 vaccination is rare and typically mild, with most patients recovering well. Myocarditis from SARS-CoV-2 infection is more severe, highlighting the favorable mRNA vaccine benefit-risk profile.
Area of Science:
- Cardiology
- Immunology
- Public Health
Background:
- Myocarditis is a rare adverse event post-mRNA COVID-19 vaccination.
- Risk factors include age, sex, dose, and vaccine type.
- Understanding its course relative to SARS-CoV-2 infection is crucial for risk assessment.
Purpose of the Study:
- To systematically review myocarditis incidence and outcomes after mRNA COVID-19 vaccination.
- To compare these outcomes with myocarditis following SARS-CoV-2 infection.
Main Methods:
- Systematic literature search of PubMed and Embase (Jan 2020-Dec 2024).
- Synthesis of cohort, registry, and surveillance data.
- Adherence to PRISMA 2020 guidelines.
Main Results:
- Vaccine-associated myocarditis is rare, predominantly in younger males after the second dose.
- Cases are generally mild, self-limiting, with high recovery rates.
- Infection-associated myocarditis shows more severe outcomes, higher hospitalization, and mortality rates.
Conclusions:
- mRNA vaccine-associated myocarditis is rare, mild, and self-limited with excellent recovery.
- Vaccinated individuals have lower odds of in-hospital death and intubation compared to infection.
- The benefit-risk balance strongly favors mRNA COVID-19 vaccination.
Related Concept Videos
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
01:22Pericarditis I: Introduction
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
01:17Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...